| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |